Congressional Testimony 2004

-

November

11/18/2004 Ensuring the Safety, Effectiveness, and Availability of Influenza and Other Vaccines
Lester M. Crawford, D.V.M., Ph.D., before the House Committee on Energy and Commerce
11/18/2004 Vioxx and Drug Safety
Sandra Kweder, M.D., before the Senate Committee on Finance
11/17/2004 Ongoing Efforts to Ensure the Safety, Effectiveness, and Availability of Influenza and Other Vaccines
Lester M. Crawford, D.V.M., Ph.D., before the House Committee on Government Reform
11/16/2004 Ensuring Safety, Effectiveness, and Availability of Influenza and Other Vaccines
Lester M. Crawford, D.V.M., Ph.D., before the Senate Special Committee on Aging

-

10/05/2004 Safety, Effectiveness, and Availability of Influenza and Other Vaccines
William Egan, Ph.D., before the House Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education and Related Agencies

-

09/23/2004 Anti-depressant Drug Use in Pediatric Populations
Robert Temple, M.D., before the House Committee on Energy and Commerce, Subcommitte on Oversight and Investigations
09/08/2004 Pediatric Clinical Trials for Anti-depressant Drug Products
Janet Woodcock, M.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
09/08/2004 Vaccine Safety
William Egan, Ph.D., before the House Committee on Government Reform, Subcommittee on Human Rights and Wellness

-

07/22/2004 Importation of Prescription Drugs
John M. Taylor, III, before the Senate Committee on Governmental Affairs, Permanent Subcommittee on Investigations
07/14/2004 Importation of Prescription Drugs
William K. Hubbard, before the Senate Committee on the Judiciary

-

06/25/2004 Implementation of the Food Security Provisions of the Public Health Security and Bioterrorism Preparedness and Response Act
Lester M. Crawford, D.V.M., Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Health
06/23/2004 The Law of Biologic Medicine
Lester M. Crawford, D.V.M., Ph.D., before the Senate Committee on the Judiciary
06/08/2004 Dietary Supplement Safety Act: How is FDA Doing 10 Years Later
Robert E. Brackett, Ph.D., before the Senate Committee on Governmental Affairs, Subcommittee on Oversight of Government Management, The Federal Workforce, and the District of Columbia
06/03/2004 Combating the Nation’s Obesity Epidemic
Lester M. Crawford, D.V.M., Ph.D., before the House Committee on Governmental Reform
06/03/2004 Combating the Obesity Epidemic
Lynn C. Swann, before the House of Government Reform

-

05/20/2004 Imported Drugs
John M. Taylor, III, before the Senate Committee on Health, Education, Labor and Pensions
05/18/2004 Conflict of Interest
Emanuel F. Petricoin III, Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Investigation and Oversight
05/18/2004 Comments on Ethics
Statement for the Record, before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
05/18/2004 Regulation of Medical Devices
Steven Gutman, M.D., before the House Committee on Government Reform, Subcommittee on Criminal Justice, Drug Policy and Human Resources
05/13/2004 Accelerating Innovative Cancer Treatments
Richard Pazdur, M.D., before the House Committee on Government Reform

-

04/27/2004 Importation of Pharmaceutical Products
William K. Hubbard, before the Senate Committee on Finance, Subcommittee on Healthcare and Subcommittee on International Trade
04/01/2004 Potential Merits of Cannabinoids for Medical Uses
Robert J. Meyer, M.D., before the House Committee on Government Reform, Subcommittee on Criminal Justice, Drug Policy, and Human Resources

-

03/30/2004 Potential Benefits of a Single Food Agency
Robert E. Brackett, Ph.D., before the House Committee on Government Reform, Subcommittee on Civil Service and Agency Organization
03/24/2004 The Status of Dietary Supplements in the United States
Robert E. Brackett, Ph.D., before the House Committee on Government Reform, Subcommittee on Human Rights and Wellness
03/18/2004 Internet Drug Sales
William K. Hubbard, before the House Committee on Government Reform
03/11/2004 Labeling of Condoms
Daniel G. Schultz, M.D., before the House Committee on Government Reform, Subcommittee on Criminal Justice, Drug Policy, and Human Resources
03/11/2004 Cost of Prescription Drugs
Mark B. McClellan, M.D., before the Senate Committee on Commerce, Science and Transportation

-

02/09/2004 Preventing Prescription Drug Abuse
Robert J. Meyer, M.D., before the House Committee on Government Reform, Subcommittee on Criminal Justice, Drug Policy, and Human Resources

-

01/27/2004 Bovine Spongiform Encephalopathy (BSE)
Lester M. Crawford, D.V.M., Ph.D., before the Senate Committee on Agriculture, Nutrition, and Forestry

-